drugset / Trial / NCT02697864

A Study Comparing Amounts of Tafamidis In The Blood Without Food

NCT02697864

Phase 1 Completed 12 enrolled Pfizer
RandomizedCrossoverOpen-labelBasic science

Summary

3 different formulations and doses of tafamidis will be compared. Subjects will be fasted for each test and every subject will test all 3 different formulations. After swallowing tafamidis, tafamidis blood concentrations will be measured periodically for 6 days. After 14 days, subjects will take a different formulation of tafamidis and tafamidis blood concentrations will be measured periodically for 6 days. After another 14 days, the last formulation will be tested in the same way.

Timeline

Start
2016-04
Primary completion
2016-06
Completion
2016-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Tafamidis Unknown 48.8 mg Oral
Subject Tafamidis Unknown 58 mg Oral
Subject Tafamidis Unknown 80 mg Oral

Indications

No indication recorded.